Filter
6001
Filtered Results: 6001
Text search:
Assessment,
monitoring
and
evaluation
Featured
Recommendations
596
New Publications
1754
Language
Document type
No document type
3618
Studies & Reports
797
Guidelines
797
Manuals
350
Strategic & Response Plan
250
Training Material
83
Fact sheets
52
Situation Updates
34
Resource Platforms
8
Infographics
6
Brochures
5
Online Courses
1
Countries / Regions
India
245
Global
242
Kenya
204
Ethiopia
147
Uganda
133
Sierra Leone
124
Nepal
123
South Africa
122
Nigeria
121
Liberia
109
Western and Central Europe
109
Myanmar / Burma
103
Malawi
98
Tanzania
97
Ghana
92
Zambia
92
Rwanda
92
Africa
75
Bangladesh
74
Syria
67
Ukraine
67
Latin America and the Carribbean
61
Philippines
57
Namibia
53
Congo, Democratic Republic of
48
Lesotho
41
Eastern Europe
41
Cambodia
40
South–East Asia Region
39
Zimbabwe
34
Guinea
33
South Sudan
33
West and Central Africa
33
Indonesia
32
East and Southern Africa
30
Mozambique
29
Haiti
28
Senegal
27
Middle East and North Africa
26
Botswana
25
Russia
23
Germany
22
Asia
22
Eastern Europe and Central Asia
21
Cameroon
20
Jordan
20
Brazil
20
Burkina Faso
19
Pakistan
19
Yemen
19
Afghanistan
18
Benin
18
Lebanon
16
Eswatini/ Swaziland
16
Sudan
13
Western Pacific Region
13
USA
12
Somalia
12
Iraq
12
Vietnam
12
Mali
10
Thailand
10
Venezuela
10
Laos
10
Tajikistan
10
Colombia
9
Albania
9
Turkey
8
China
7
Madagascar
7
Georgia
7
Angola
6
Sri Lanka
6
Iran
6
Saudi Arabia
5
Egypt
5
Central African Republic
5
Argentina
5
Peru
5
Libya
5
Timor Leste/ East Timor
5
Côte d’Ivoire / Ivory Coast
4
Niger
4
Chad
4
Gambia
4
Paraguay
4
Bhutan
4
Southern Africa
4
Moldova
4
Kyrgyzstan
4
Spain
4
Mauritania
3
North Macedonia
3
Croatia
3
Burundi
3
Palestine
3
Armenia
3
Canada
3
Qatar
3
Kazakhstan
3
North America
3
United Kingdom
3
Portugal
3
Bosnia and Herzegovina
3
Guinea-Bissau
2
Morocco
2
Togo
2
Singapore
2
Serbia
2
Honduras
2
Bolivia
2
Greece
2
Mexico
2
Italy
2
Estonia
2
Romania
2
Lithuania
2
Turkmenistan
2
France
2
Mauritius
2
Tunisia
2
Israel
2
Malaysia
1
Ireland
1
Papua New Guinea
1
Vanuatu
1
Dominican Republic
1
Ecuador
1
El Salvador
1
Guatemala
1
Nicaragua
1
Chile
1
Fiji
1
Poland
1
North Korea
1
Djibouti
1
Congo-Brazzaville
1
Bulgaria
1
Uruguay
1
Jamaica
1
Japan
1
Denmark
1
Maldives
1
Azerbaijan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
2295
Clinical Guidelines
487
Key Resources
368
Public Health
351
Women & Child Health
324
Capacity Building
125
Pharmacy & Technologies
64
Toolboxes
HIV
429
Mental Health
391
COVID-19
354
TB
322
Disability
225
Planetary Health
202
Rapid Response
200
AMR
185
Conflict
171
Ebola
170
Caregiver
169
NTDs
128
NCDs
109
Natural Hazards
100
Pharmacy
98
Global Health Education
87
Refugee
85
Specific Hazards
43
Health Financing Toolbox
38
Cholera
33
Polio
32
Zika
32
Social Ethics
7
Typhoon
5
South Sudan
1
Health Financing
1
This document provides up-to-date guidance on laboratory studies as well as smallscale (semi-field) and large-scale field trials to assess the efficacy and determine field
application rates of ne...
A workshop of “first mover” countries to exchange experience and identify wider policy implications for the WHO European Region
The World Health Organization (WHO) European Region continues to be severely affected by diet-related noncommunicabl...
Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory diseases and their risk factors are an increasing public health ... development challenge in Turkey. This report provides evidence through three analyses that NCDs reduce economic output, and discusses potential options in response, outlining details of their relative returns on investment. An economic burden analysis shows that economic losses from NCDs are equivalent to 3.6% of gross domestic product. An intervention costing analysis provides an estimate of the funding required to implement a set of policy interventions for prevention and clinical interventions. A cost–benefit analysis compares these implementation costs with the estimated health gains and identifies which policy packages would give the greatest returns on investment.
BMJ Global Health2020;5:e001980. doi:10.1136/bmjgh-2019-00198
BMJ Global Health2020;5:e002014. doi:10.1136/bmjgh-2019-002014
Interim Framework for the South-East Asia Region 28 October 2020
The right to adequate housing, despite having been recognized by multiple international instruments, continues to be a human right that is consistently violated. Around 2O% of the world's population do not have adequate housing . In Latin America, informal settlements generally lack the conditions r...
Access to medical personal protective equipment (PPE) is essential for routine healthcare delivery, and a critical tool for containing outbreaks, as well as preventing and responding to pandemics. I...
The standards for the care of small and sick newborns in health facilities define, standardize and mainstream inpatient care of small and sick newb...
Lancet Public health 2022 January 6, 2022 https://doi.org/10.1016/ S2468-2667(21)00249-8
Growth in the number of individuals living with dementia underscores the need for public health planning efforts and policy to address the needs of this group....
In 2015, 26% of the deaths of 5.9 million children who died before reaching their fifth birthday could have been prevented
through addressing environmental risks – a shocking missed opportunity. The prenatal and early childhood period represents
...
Surveillance, case investigation and contact tracing for monkeypox: interim guidance 24 June 2022
recommended
The overall goal of surveillance, case investigation and contact tracing in this context is to stop human-to-human transmission to control the outbreak. The key objectives of surveillance and case i...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children ... young persons. The guidance also addresses considerations for clinical management such as the use of therapeutics, nutritional support, mental health services, and post-infection follow-up.
The document provides guidance for clinicians, health facility managers, health workers and infection prevention and control practitioners including but not limited to those working in primary care clinics, sexual health clinics, emergency departments, infectious diseases clinics, genitourinary clinics, dermatology clinics, maternity services, paediatrics, obstetrics and gynaecology and acute care facilities that provide care for patients with suspected or confirmed monkeypox
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, ... the policies and strategies implemented by countries and health systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission ... elimination of leprosy disease and through the post-elimination period. Importantly, it provides criteria with benchmarks, where possible, for all key aspects of leprosy programmes and services. Not only those related to elimination efforts, but also those related to diagnosis and management of leprosy, leprosy-related disabilities, mental wellbeing, stigma and discrimination and inclusion and participation of persons affected by leprosy. The document emphasises that the elimination of leprosy is a long-term, continuous journey on the one hand, while, on the other, clear milestones can be recognised on the way and programme implementation can be assessed against benchmarks, guiding appropriate action to keep the programme on track.
Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory diseases – along with mental health, cause nearly...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, ... the policies and strategies implemented by countries and health systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
